161 related articles for article (PubMed ID: 16216950)
41. [Oral rehabilitation of a patient with Wilson-syndrome using MK1 bolt attachment. A case report].
Károlyházy K; Kivovics P; Faluhelyi P; Fejérdy P
Fogorv Sz; 2006 Oct; 99(5):201-4. PubMed ID: 17183790
[TBL] [Abstract][Full Text] [Related]
42. Polyneuropathies in the elderly: a clinico pathological study of 74 cases.
Kararizou E; Davaki P; Karandreas N; Davou R; Vassilopoulos D
Int J Neurosci; 2006 May; 116(5):629-38. PubMed ID: 16644522
[TBL] [Abstract][Full Text] [Related]
43. Motor variant of chronic inflammatory demyelinating polyneuropathy in a child.
Sinno DD; Darras BT; Yamout BI; Rebeiz JG; Mikati MA
Pediatr Neurol; 2008 Jun; 38(6):426-9. PubMed ID: 18486826
[TBL] [Abstract][Full Text] [Related]
44. Was Cavum Septum Pellucidum the Cause of Intractable Seizure in a 17-Year-Old Boy with Wilson Disease?
Rahman A; Haque SU; Bhandari PB; Alam S
World Neurosurg; 2017 Sep; 105():1035.e5-1035.e10. PubMed ID: 28619500
[TBL] [Abstract][Full Text] [Related]
45. Synchronized brain network underlying postural tremor in Wilson's disease.
Südmeyer M; Pollok B; Hefter H; Gross J; Butz M; Wojtecki L; Timmermann L; Schnitzler A
Mov Disord; 2006 Nov; 21(11):1935-40. PubMed ID: 16991150
[TBL] [Abstract][Full Text] [Related]
46. Clinical and electrophysiologic evaluation of peripheral neuropathy in a group of HIV-infected patients in Thailand.
Konchalard K; Wangphonpattanasiri K
J Med Assoc Thai; 2007 Apr; 90(4):774-81. PubMed ID: 17487134
[TBL] [Abstract][Full Text] [Related]
47. [Nephrolithiasis as an initial clinical manifestation of Wilson-Konovalov disease].
Rakhimova OIu; Rozina TP; Ignatova TM
Ter Arkh; 2003; 75(6):60-2. PubMed ID: 12920963
[No Abstract] [Full Text] [Related]
48. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
49. Sensory neuropathy as the initial manifestation of multiple system atrophy.
Wu YR; Chen CM; Ro LS; Lyu RK; Tang LM
J Formos Med Assoc; 2004 Sep; 103(9):727-30. PubMed ID: 15361949
[TBL] [Abstract][Full Text] [Related]
50. Video documented follow-up of liver transplantation in Wilson's disease with predominant neurological manifestation.
Suess T; Bokemeyer M; Schomerus G; Donnerstag F; Manns MP; Klempnauer J; Kolbe H; Weissenborn K
Mov Disord; 2007 May; 22(7):1036-8. PubMed ID: 17357135
[TBL] [Abstract][Full Text] [Related]
51. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
Perkins BA; Grewal J; Ng E; Ngo M; Bril V
Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
[TBL] [Abstract][Full Text] [Related]
52. Delayed oxaliplatin-induced sensorimotor polyneuropathy.
Nardone R; Buratti T; Golaszewski S; Bratti A; Caleri F; Tezzon F; Ladurner G; Mitterer M
Onkologie; 2009 May; 32(5):283-5. PubMed ID: 19420977
[TBL] [Abstract][Full Text] [Related]
53. Monozygotic female twins discordant for phenotype of Wilson's disease.
Członkowska A; Gromadzka G; Chabik G
Mov Disord; 2009 May; 24(7):1066-9. PubMed ID: 19306278
[TBL] [Abstract][Full Text] [Related]
54. Acute extrapyramidal syndrome and seizures as heralding manifestation of Wilson disease.
Verma R; Patil TB; Lalla RS
Neurol India; 2012; 60(3):363-4. PubMed ID: 22824716
[No Abstract] [Full Text] [Related]
55. Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy.
Hashizume A; Koike H; Kawagashira Y; Banno H; Suzuki K; Ito M; Katsuno M; Watanabe H; Tanaka F; Naganawa S; Kaneko R; Ishii A; Sobue G
Clin Neurol Neurosurg; 2011 Jul; 113(6):493-5. PubMed ID: 21349632
[No Abstract] [Full Text] [Related]
56. Electrocardiographic Manifestations In Paediatric Wilson Disease.
Batool Hamdani SS; Cheema HA; Saeed A; Malik HS; Sehar T
J Ayub Med Coll Abbottabad; 2018; 30(1):22-25. PubMed ID: 29504323
[TBL] [Abstract][Full Text] [Related]
57. A novel Global Assessment Scale for Wilson's Disease (GAS for WD).
Aggarwal A; Aggarwal N; Nagral A; Jankharia G; Bhatt M
Mov Disord; 2009 Mar; 24(4):509-18. PubMed ID: 19115420
[TBL] [Abstract][Full Text] [Related]
58. NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement.
Echaniz-Laguna A; Degos B; Bonnet C; Latour P; Hamadouche T; Lévy N; Leheup B
Neuromuscul Disord; 2007 Feb; 17(2):163-8. PubMed ID: 17142040
[TBL] [Abstract][Full Text] [Related]
59. [Acute polyneuropathy and encephalopathy caused by arsenic poisoning].
Berbel-García A; González-Aguirre JM; Botia-Paniagua E; Orts-Castro E; López-Zuazo I; Rodríguez-García JL; Gil-Madre J
Rev Neurol; 2004 May 16-31; 38(10):928-30. PubMed ID: 15175974
[TBL] [Abstract][Full Text] [Related]
60. [Chronic polyneuropathy--evaluation and diagnosis].
Mygland A
Tidsskr Nor Laegeforen; 2007 Feb; 127(3):291-5. PubMed ID: 17279107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
